The hope with each one is that it could lead to a viable treatment to cure or alleviate that condition. It is easy, therefore, to think that a successful trial is one that produces such a treatment, while any other result is a failure. Not so, as a recent study from Oxford's researchers in South East Asia shows.
Cryptococcal meningitis is a fungal infection of the brain, which primarily affects people living with HIV. The disease is estimated to cause over 600,000 deaths each year, with the majority of cases occurring in sub-Saharan Africa and Asia.
Read more (Oxford Science blog)